Elevated levels of p-tau 181 and 217 in cerebrospinal fluid are considered to reflect early Alzheimer's disease pathology.

For more than three decades, scientists have been racing to stop Alzheimer's disease by removing amyloid beta plaques—sticky ...

A new study by Mass General Brigham researchers has found faster accumulation of tau—a key indicator of Alzheimer's ...

After Eli Lilly and Biogen’s setbacks in developing O-GlaNAcase (OGA) inhibitors for Alzheimer’s disease, Asceneuron has now ...

Sex differences in tau may help explain why women face higher Alzheimer's dementia risk than men. At high levels of brain ...

Researchers at Northwestern University have made a breakthrough in identifying a way for Alzheimer's disease to be treated ...

USC Stem Cell scientists discover a new way to rid cells of toxic tau protein in a study involving mice and lab-grown human ...

Tau build-up in the brain is associated with Alzheimer’s disease progression. “This unusual pattern might be indicative of ...

Phosphorylated tau 217 better detected Alzheimer’s disease pathology across a range of neurodegenerative syndromes compared ...

A new biomarker test can detect early-stage tau protein clumping up to a decade before it appears on brain scans, improving ...

2025 — A complementary drug to combat Alzheimer's disease could target a specific part of the nerve cell protein tau. This is the finding of new research which also offers a better way to ...

A special edition of the journal Science focuses on women's health, including links between estrogen and dementia, at a time ...